There's a bit to happen before a class action can be launched... first step is to see the company's response the ASX aware letter... then if a takeover bid is launched - what is the price... The higher the price the less "damage" has been done. And finally, getting a definitive investigation into all the other financials. Don't forget that the ASX allowed Quintis to trade again after they responded to Glaucus. The only discrepancy Quintis have admitted to so far is the Galderma situation. And with Galderma they are saying they didn't include it in their Sales forecasts and guidance.. Still, obviously it is a material announcement which they stuffed up. Don't get me wrong I'm not defending Quintis, and they have a lot to answer for. Just saying there is a lot of information we need to get before making any final judgements on liability and the future of the company.
QIN Price at posting:
29.5¢ Sentiment: Hold Disclosure: Held
